A single-nucleus transcriptomic characterization of EGFR G719X/S768I double-mutant lung adenocarcinoma identifies an immunosuppressive niche defined by COL4A3-CD44 interaction

This publication has 65 references indexed in Scilit:

• CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer
  Cancer Communications, 2025
• Transcription factor EGR2 drives cataract formation through IGFBP3-mediated oxidative injury in lens epithelial cells
  Free Radical Biology and Medicine, 2025
• Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
  Acta Pharmaceutica Sinica B, 2025
• Intricate relationship between cancer stemness, metastasis, and drug resistance
  Medcomm, 2024
• Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
  Molecular and Cellular Biochemistry, 2024
• Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue
  Cellular Oncology, 2024
• HOXA9 transcription factor is a double-edged sword: from development to cancer progression
  Cancer and Metastasis Reviews, 2023
• Integrated analysis of multimodal single-cell data
  Cell, 2021
• Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
  Cell, 2017
• High COL4A3 expression correlates with poor prognosis after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer
  Tumor Biology, 2012